176 related articles for article (PubMed ID: 26362253)
41. Conditional depletion of intellectual disability and Parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and neurodegeneration.
Dubos A; Castells-Nobau A; Meziane H; Oortveld MA; Houbaert X; Iacono G; Martin C; Mittelhaeuser C; Lalanne V; Kramer JM; Bhukel A; Quentin C; Slabbert J; Verstreken P; Sigrist SJ; Messaddeq N; Birling MC; Selloum M; Stunnenberg HG; Humeau Y; Schenck A; Herault Y
Hum Mol Genet; 2015 Dec; 24(23):6736-55. PubMed ID: 26376863
[TBL] [Abstract][Full Text] [Related]
42. Distribution of α-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons.
Sumikura H; Takao M; Hatsuta H; Ito S; Nakano Y; Uchino A; Nogami A; Saito Y; Mochizuki H; Murayama S
Acta Neuropathol Commun; 2015 Sep; 3():57. PubMed ID: 26374630
[TBL] [Abstract][Full Text] [Related]
43. Rab7 induces clearance of α-synuclein aggregates.
Dinter E; Saridaki T; Nippold M; Plum S; Diederichs L; Komnig D; Fensky L; May C; Marcus K; Voigt A; Schulz JB; Falkenburger BH
J Neurochem; 2016 Sep; 138(5):758-74. PubMed ID: 27333324
[TBL] [Abstract][Full Text] [Related]
44. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.
Caudal D; Alvarsson A; Björklund A; Svenningsson P
Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495
[TBL] [Abstract][Full Text] [Related]
45. Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation.
Bae EJ; Yang NY; Lee C; Lee HJ; Kim S; Sardi SP; Lee SJ
Exp Mol Med; 2015 Oct; 47(10):e188. PubMed ID: 26427853
[No Abstract] [Full Text] [Related]
46. Visualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based Probes.
Herrera Moro Chao D; Kallemeijn WW; Marques AR; Orre M; Ottenhoff R; van Roomen C; Foppen E; Renner MC; Moeton M; van Eijk M; Boot RG; Kamphuis W; Hol EM; Aten J; Overkleeft HS; Kalsbeek A; Aerts JM
PLoS One; 2015; 10(9):e0138107. PubMed ID: 26418157
[TBL] [Abstract][Full Text] [Related]
47. Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease.
Oeda T; Umemura A; Mori Y; Tomita S; Kohsaka M; Park K; Inoue K; Fujimura H; Hasegawa H; Sugiyama H; Sawada H
Neurobiol Aging; 2015 Dec; 36(12):3306-3313. PubMed ID: 26422360
[TBL] [Abstract][Full Text] [Related]
48. Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced α-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations.
Sharma N; Kapoor M; Nehru B
Behav Brain Res; 2016 Jan; 296():177-190. PubMed ID: 26367469
[TBL] [Abstract][Full Text] [Related]
49. Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages.
Aflaki E; Moaven N; Borger DK; Lopez G; Westbroek W; Chae JJ; Marugan J; Patnaik S; Maniwang E; Gonzalez AN; Sidransky E
Aging Cell; 2016 Feb; 15(1):77-88. PubMed ID: 26486234
[TBL] [Abstract][Full Text] [Related]
50. Cell Models to Study Cell-to-Cell Transmission of α-Synuclein.
Bae EJ; Lee HJ; Lee SJ
Methods Mol Biol; 2016; 1345():291-8. PubMed ID: 26453220
[TBL] [Abstract][Full Text] [Related]
51. Formation and Characterization of α-Synuclein Oligomers.
Paslawski W; Lorenzen N; Otzen DE
Methods Mol Biol; 2016; 1345():133-50. PubMed ID: 26453210
[TBL] [Abstract][Full Text] [Related]
52. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Uchihara T; Giasson BI
Acta Neuropathol; 2016 Jan; 131(1):49-73. PubMed ID: 26446103
[TBL] [Abstract][Full Text] [Related]
53. From rare to common and back again: 60years of lysosomal dysfunction.
Coutinho MF; Alves S
Mol Genet Metab; 2016 Feb; 117(2):53-65. PubMed ID: 26422115
[TBL] [Abstract][Full Text] [Related]
54. Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric α-Synuclein and Reduce Its Aggregation in Cells.
Moree B; Yin G; Lázaro DF; Munari F; Strohäker T; Giller K; Becker S; Outeiro TF; Zweckstetter M; Salafsky J
J Biol Chem; 2015 Nov; 290(46):27582-93. PubMed ID: 26396193
[TBL] [Abstract][Full Text] [Related]
55. A novel link between the conformations, exposure of specific epitopes, and subcellular localization of α-synuclein.
Nam MK; Han JH; Jang JY; Yun SE; Kim GY; Kang S; Rhim H
Biochim Biophys Acta; 2015 Dec; 1850(12):2497-505. PubMed ID: 26391842
[TBL] [Abstract][Full Text] [Related]
56. Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).
Follmer C; Coelho-Cerqueira E; Yatabe-Franco DY; Araujo GD; Pinheiro AS; Domont GB; Eliezer D
J Biol Chem; 2015 Nov; 290(46):27660-79. PubMed ID: 26381411
[TBL] [Abstract][Full Text] [Related]
57. Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses.
Wilkaniec A; Czapski GA; Adamczyk A
J Neurochem; 2016 Jan; 136(2):222-33. PubMed ID: 26376455
[TBL] [Abstract][Full Text] [Related]
58. The PINK1-PARKIN Mitochondrial Ubiquitylation Pathway Drives a Program of OPTN/NDP52 Recruitment and TBK1 Activation to Promote Mitophagy.
Heo JM; Ordureau A; Paulo JA; Rinehart J; Harper JW
Mol Cell; 2015 Oct; 60(1):7-20. PubMed ID: 26365381
[TBL] [Abstract][Full Text] [Related]
59. Longitudinal study of normal cognition in Parkinson disease.
Pigott K; Rick J; Xie SX; Hurtig H; Chen-Plotkin A; Duda JE; Morley JF; Chahine LM; Dahodwala N; Akhtar RS; Siderowf A; Trojanowski JQ; Weintraub D
Neurology; 2015 Oct; 85(15):1276-82. PubMed ID: 26362285
[TBL] [Abstract][Full Text] [Related]
60. The contribution of mutant GBA to the development of Parkinson disease in Drosophila.
Maor G; Cabasso O; Krivoruk O; Rodriguez J; Steller H; Segal D; Horowitz M
Hum Mol Genet; 2016 Jul; 25(13):2712-2727. PubMed ID: 27162249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
